PI
ANAB icon

Putnam Investments’s AnaptysBio ANAB Stock Holding History

Putnam Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,513
Closed -$383K – 1125
2022
Q1 		$383K Sell
15,513
-1,213
-7% -$36.7K ﹤0.01% 1090
2021
Q4 		$581K Buy
+16,726
New +$530K ﹤0.01% 929
2019
Q2 		– Sell
-68,100
Closed -$4.97M – 884
2019
Q1 		$4.97M Hold
68,100
– – 0.01% 508
2018
Q4 		$4.34M Sell
68,100
-17,816
-21% -$1.32M 0.01% 497
2018
Q3 		$8.57M Buy
+85,916
New +$7.13M 0.02% 426

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Putnam Investments's ANAB Position: Q2 2022 in Review

Putnam Investments sold out of AnaptysBio (ANAB) in Q2 2022, closing a stake of 15,513 shares — an estimated $383K sold.

Putnam Investments first reported a position in ANAB in Q3 2018 and held it in 5 quarters. The position peaked at $8.57M in Q3 2018. 124 funds tracked by Wall St. Rank hold ANAB as of Q2 2022.

  • Putnam Investments reported no remaining AnaptysBio position as of Q2 2022 after selling out during the quarter.
  • Putnam Investments sold 15,513 AnaptysBio shares in Q2 2022, an estimated $383K.
  • Putnam Investments first reported a position in AnaptysBio in Q3 2018 and held it in 5 quarters.
  • Putnam Investments's AnaptysBio position peaked at $8.57M in Q3 2018.
  • 124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.